Damar Batu as a novel matrix former for the transdermal drug delivery: in vitro evaluation Damar Batu: Novel matrix former for TDDS

Drug Development and Industrial Pharmacy

Volumn 35, Issue 9, 2009, Pages 1147-1154

  Mundada, A S ^a   Avari, J G ^a  

^a RTM NAGPUR UNIVERSITY   (India)

Author keywords

Diltiazem hydrochloride; In vitro permeation; In vitro release; Matrix system; Transdermal drug delivery

Indexed keywords

BIOMATERIAL; DAMAR BATU; DILTIAZEM; EUDRAGIT; UNCLASSIFIED DRUG;

ACIDITY; ANIMAL TISSUE; ARTICLE; CHEMICAL INTERACTION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; ERYTHEMA; GLASS TRANSITION TEMPERATURE; MOLECULAR MECHANICS; MOLECULAR WEIGHT; NONHUMAN; RAT; SKIN EDEMA; SKIN IRRITATION; SKIN PERMEABILITY; THICKNESS; TRANSDERMAL PATCH;

ADMINISTRATION, CUTANEOUS; ANIMALS; CHROMATOGRAPHY, THIN LAYER; DIFFUSION CHAMBERS, CULTURE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; IRRITANTS; MEMBRANES, ARTIFICIAL; POLYMERS; RATS; RATS, WISTAR; RESINS, PLANT; SKIN ABSORPTION; SOLUBILITY; SPECTROPHOTOMETRY, INFRARED; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 70350672556     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040902882249     Document Type: Article

References (34)

1. Chien YW. (1983). Comparative controlled skin permeation of nitroglycerin from marketed transdermal delivery systems. J Pharm Sci, 72:968-970
2. Loftsson T, Gildersleeve N, Border N. (1987). The effect of vehicle additives on the transdermal delivery of nitroglycerin. Pharm Res, 4:436-444
3. Corbo M, Liu JC, Chien YW. (1990). Bioavailability of propranolol following oral & transdermal administration in rabbits. J Pharm Sci, 79:584-587
4. Aqil M, Sultana Y, Ali A. (2003). Matrix type transdermal drug delivery systems of metoprolol tartrate: In vitro characterization. Acta Pharm, 53:119-125
5. Williams AC, Barry BW. (2004). Penetration enhancers. Adv Drug Deliv Rev, 56:603-618
6. Bohme K. (2002). Buprenorphine in a transdermal therapeutic system-A new option. Clin Rheumatol, 21(1):S13-6.
7. Anon. (1959). Dewaxed damar-A review. Paint Oil Colour J, 11:215-218
8. Anon. (1973). Damar FPRI Technical Note No. 136. Laguna, the Philippines: Forest Products Research and Industries Development Commission, 3.
9. Mundada AS, Satturwar PM, Fulzele SV, Joshi SB, Dorle AK. (2009). Damar Batu: Novel film forming polymer for drug delivery. Drug Deliv Tech, in press.
10. Kerins DM, Robertson RM, Robertson D. (2001). Drugs used for the treatment of myocardial ischemia. In: Hardman JG, Limbird LE, Gilman AG, eds. Goodman Gilman's: The pharmacological basis of therapeutics. 10th ed. Columbus (OH): McGraw Hill Comp., 856-859
11. Raynolds JEF. (1996). Martindale: The extra pharmacopoeia. 31st ed. London: Royal Pharmaceutical Society, 857.
12. Rao RP, Diwan PV. (1998). Formulation and in vitro evaluation of polymeric films of diltiazem hydrochloride and indomethacin for transdermal administration. Drug Dev Ind Pharm, 24:327-336
13. Gupta R, Mukherjee B. (2003). Development and in vitro evaluation of diltiazem hydrochloride transdermal patches on povidone- ethylcellulose matrices. Drug Dev Ind Pharm, 29:1-7.
14. Jain SK, Chaurasia MK, Sabitha M, Jain R, Jain AK, Ashawat M, et al. (2003). Development and characterization of transdermal drug delivery systems for diltiazem hydrochloride. Drug Deliv, 10:169-177
15. Mundada AS, Shrikhande BK. (2006). Design and evaluation of soluble ocular drug insert for controlled release of ciprofloxacin hydrochloride. Drug Dev Ind Pharm, 32:443-448
16. Seth AK, Agrawal GP, Saini TR. (1985). Evaluation of free films. Ind Drugs, 23:45-47
17. ASTM Standards, D882-95a. (1995). Tensile properties of thin plastic sheeting. West Conshohocken (PA): American Society for Testing and Materials.
18. Ubaidulla U, Reddy MVS, Ruckmani K, Ahmed FJ, Khar RK. (2007). Transdermal therapeutic system of carvedilol: Effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics. AAPS PharmSciTech, 8(1):E1-8.
19. Mazzo DJ, Obetz CL, Shuster J. (1994). In: Brittain HG, ed. Analytical profiles of drug substances and excipients, vol.23. San Diego, CA: Academic Press Inc., 53.
20. US Pharmacopeia XXIII. (1995). US Pharmacopoeial convention. Rockville, MD, pp. 1796.
21. Berner B, Mazzenga GC, Otte JH, Steffens RJ, Juang RH, Ebert CD. (1989). Ethanol: water mutually enhanced transdermal therapeutic system II: Skin permeation of ethanol and nitroglycerine. J Pharm Sci, 78:402-407 (Pubitemid 20070550)
22. Chien YW, Valia KH. (1984). Development of a dynamic skin permeation system for long term studies. Drug Dev Ind Pharm, 10:575-599
23. Sarpotdar PP, Gaskill JL, Giannini RP. (1986). Effect of polyethylene glycol 400 on the penetration of drugs through human cadaver skin in vitro. J Pharm Sci, 75:26-28
24. Bonina FP, Carellii V, Cols GD, Montenegro L, Nannipieri E. (1993). Vehicle effects on in vitro skin permeation and stratum corneum affinity for model drugs caffeine and testosterone. Int J Pharm, 100:41-47
25. Mutalik S, Udupa N. (2004). Glibenclamide transdermal patches: Physicochemical, pharmacodynamic, and pharmacokinetic evaluations. J Pharm Sci, 93:1577-1594
26. Draize JH, Woodward GS, Calvery HO. (1944). Method for the study of irritation and toxicity of substances applied topically to the skin and mucus membrane. J Pharmacol Exp Ther, 82:377-390
27. Aqil M, Ali A. (2002). Monolithic matrix type transdermal drug delivery systems of pinacidil monohydrate: In vitro characterization. Eur J Pharm Biopharm, 54:161-164
28. Lopez CR, Bodmeier R. (1996). Mechanical and water vapor transmission properties of polysaccharide films. Drug Dev Ind Pharm, 22:1201-1209
29. Sood A, Panchagnula R. (1999). Role of dissolution studies in controlled release drug delivery system. STP Pharm Sci, 9:157-168
30. Bodmeier R, Paeratakul O. (1990). Theophylline tablets coated with aqueous latexes containing dispersed pore formers. J Pharm Sci, 79:32.
31. Rao RP, Ramakrishna S, Diwan PV. (2000). Drug release kinetics from polymeric films containing propranolol hydrochloride for transdermal use. Pharm Dev Tech, 5:465-472
32. Katayose S, Kataoka K. (1997). Water-soluble polyion complex associates of DNA and poly(ethylene glycol)-poly(L-lysine) block copolymer. Bioconjug Chem, 8:702-707 (Pubitemid 27416084)
33. Chien YW. (1987). Development of transdermal drug delivery system. Drug Dev Ind Pharm, 13:589-651.
34. Chang RK, Peng Y, Shukla AJ. (2006). Polymethacrylates. In: Rowe RC, Sheskey PJ, Owen SC, eds. Handbook of phramaceutical excipients. 5th ed. London: Pharmaceutical Press, 553-560